Dorian LPG
LPG
Hutchmed (China)
HCM
Collegium Pharmaceutical
COLL
4
Halozyme Therapeutics
HALO
5
Precision Drilling
PDS
(Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -8.49%46.72M | -13.70%46.06M | -13.00%202.98M | -11.38%49.38M | -11.82%49.18M | -14.86%51.05M | -13.74%53.37M | -15.45%233.33M | -15.67%55.72M | -12.60%55.77M |
Operating revenue | -8.49%46.72M | -13.70%46.06M | -13.00%202.98M | -11.38%49.38M | -11.82%49.18M | -14.86%51.05M | -13.74%53.37M | -15.45%233.33M | -15.67%55.72M | -12.60%55.77M |
Cost of revenue | -14.89%27.46M | -16.93%28.03M | -19.36%126.44M | -17.51%29.36M | -17.24%31.08M | -22.46%32.26M | -19.73%33.74M | -25.46%156.78M | -25.84%35.59M | -31.62%37.55M |
Gross profit | 2.50%19.26M | -8.15%18.03M | 0.00%76.55M | -0.53%20.02M | -0.65%18.11M | 2.35%18.79M | -1.03%19.63M | 16.65%76.54M | 11.32%20.12M | 104.79%18.22M |
Operating expense | -0.57%13.76M | 27.45%15.54M | -18.93%54.86M | -10.24%14.8M | -13.36%14.02M | -21.48%13.84M | -29.77%12.2M | -16.32%67.66M | -15.00%16.48M | -8.38%16.18M |
Selling and administrative expenses | 1.05%13.3M | 27.67%15.1M | -15.07%50.91M | -12.91%12.91M | -14.25%13.01M | -4.85%13.17M | -26.61%11.83M | -19.68%59.95M | -17.36%14.82M | -5.40%15.18M |
-General and administrative expense | 1.05%13.3M | 27.67%15.1M | -15.07%50.91M | -12.91%12.91M | -14.25%13.01M | -4.85%13.17M | -26.61%11.83M | -19.68%59.95M | -17.36%14.82M | -5.40%15.18M |
Depreciation amortization depletion | -32.05%460K | 20.54%446K | -48.87%3.95M | 13.52%1.89M | 0.10%1.01M | -82.15%677K | -70.42%370K | 23.97%7.72M | 14.13%1.66M | -37.85%1.01M |
-Depreciation and amortization | -32.05%460K | 20.54%446K | -48.87%3.95M | 13.52%1.89M | 0.10%1.01M | -82.15%677K | -70.42%370K | 23.97%7.72M | 14.13%1.66M | -37.85%1.01M |
Operating profit | 11.07%5.5M | -66.56%2.49M | 144.23%21.69M | 43.43%5.22M | 100.20%4.08M | 577.95%4.95M | 200.97%7.43M | 158.28%8.88M | 377.02%3.64M | 123.27%2.04M |
Net non-operating interest income expense | 21.65%-4.85M | 21.69%-4.85M | -14.69%-25.39M | 23.89%-6.86M | -28.54%-6.15M | -36.93%-6.19M | -62.12%-6.19M | -71.45%-22.14M | -173.85%-9.02M | -48.48%-4.79M |
Non-operating interest expense | -21.65%4.85M | -21.69%4.85M | 14.69%25.39M | -23.89%6.86M | 28.54%6.15M | 36.93%6.19M | 62.12%6.19M | 71.45%22.14M | 173.85%9.02M | 48.48%4.79M |
Other net income (expense) | -337.98%-307K | 262.50%325K | 7,314.17%93.64M | 70,584.21%94.01M | -186.38%-298K | -89.66%129K | 56.80%-200K | 107.75%1.26M | 129.30%133K | 102.50%345K |
Special income (charges) | --0 | ---352K | 92,984.16%93.81M | 144,689.23%93.98M | --0 | ---170K | --0 | 99.37%-101K | 55.17%-65K | 99.74%-36K |
-Less:Impairment of capital assets | --0 | --352K | 690.10%798K | 866.15%628K | --0 | --170K | --0 | -99.26%101K | --65K | -99.73%36K |
-Less:Other special charges | ---- | ---- | ---94.61M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Gain on sale of property,plant,equipment | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Other non- operating income (expenses) | -202.68%-307K | 438.50%677K | -112.61%-172K | -86.36%27K | -178.22%-298K | -76.04%299K | 56.80%-200K | 560.81%1.36M | 164.08%198K | 149.02%381K |
Income before tax | 130.81%342K | -294.55%-2.04M | 849.59%89.94M | 1,861.05%92.37M | 1.46%-2.37M | 56.32%-1.11M | 157.79%1.05M | 73.00%-12M | -3.64%-5.25M | 90.68%-2.4M |
Income tax | 227.10%136K | -52.03%-225K | 232.67%869K | 342.08%1.07M | 122.41%54K | -107K | -628.57%-148K | -132.47%-655K | -112.63%-442K | 81.02%-241K |
Net income | 666.80%7.65M | -171.44%-853K | 1,333.04%91.06M | 1,998.83%91.2M | -41.94%-2.33M | 141.42%997K | -18.66%1.19M | 91.40%-7.39M | 88.73%-4.8M | 94.11%-1.64M |
Net income continuous Operations | 120.54%206K | -251.59%-1.81M | 885.22%89.07M | 2,000.83%91.3M | -12.03%-2.42M | 60.53%-1M | 164.96%1.19M | 75.58%-11.34M | 43.89%-4.8M | 91.18%-2.16M |
Net income discontinuous operations | 271.95%7.44M | --957K | -49.65%1.99M | ---96K | -82.82%89K | 1,392.54%2M | --0 | 110.05%3.96M | --0 | 115.19%518K |
Minority interest income | ||||||||||
Net income attributable to the parent company | 666.80%7.65M | -171.44%-853K | 1,333.04%91.06M | 1,998.83%91.2M | -41.94%-2.33M | 141.42%997K | -18.66%1.19M | 91.40%-7.39M | 88.73%-4.8M | 94.11%-1.64M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 666.80%7.65M | -171.44%-853K | 1,333.04%91.06M | 1,998.83%91.2M | -41.94%-2.33M | 141.42%997K | -18.66%1.19M | 91.40%-7.39M | 88.73%-4.8M | 94.11%-1.64M |
Basic earnings per share | 665.12%3.29 | -170.59%-0.36 | 1,324.21%38.93 | 1,992.72%38.99 | -40.85%-1 | 141.35%0.43 | -15.00%0.51 | 91.93%-3.18 | 88.92%-2.06 | 94.18%-0.71 |
Diluted earnings per share | 530.23%2.71 | -170.59%-0.36 | 1,305.66%38.34 | 1,964.08%38.4 | -40.85%-1 | 141.35%0.43 | -15.00%0.51 | 91.93%-3.18 | 88.92%-2.06 | 94.18%-0.71 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |